Publications by authors named "Arianna Annunziata"
[Not Available].
Recenti Prog Med
December 2024
Aim of the study was to assess the use of pharmacological therapies provided in Nursing Homes and Protected Residences of the Umbria Region, with reference to central nervous system medications. In 2022, 200 ddd (defined daily doses) per 100 bed-days were administered in Umbria's long term care facilities, representing a 6.2% decrease compared to the previous year.
View Article and Find Full Text PDFObjectives: To assess the safety profile of dietary supplements with a focus on those purchased online or reported via the internet.
Results: Among the 2,367 reports of Adverse Reactions (ARs) to dietary supplements collected within the Italian Phitovigilance System, 49.4% were from citizens and 33.
Introduction: Chronic diseases, such as hemophilia, can evoke psychological sequelae and be associated with a higher risk of mental health disorders. The utilization of antidepressant and antipsychotic drugs in subjects with hemophilia is not completely understood and few data are available.
Objectives: The aim of this analysis is to describe use of antidepressant and antipsychotic drugs in subjects with hemophilia of the Umbria Region in the period 2011-2022.
Article Synopsis
- The study aims to evaluate how changing therapy days for haemophilia B medications could affect spending compared to 2022.
- It analyzes data on all coagulation factor IX products used in Italy to estimate potential cost changes by switching 5% to 20% of therapy days to a new treatment, nonacog beta pegol.
- Results suggest that overall spending on haemophilia B treatments may stay the same or decrease slightly (by up to 2.26%), contrasting with previous years' increasing costs, indicating the need for better pharmaceutical management.